These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4124713)

  • 1. Antigenic determinant of Salmonella lipopolysaccharide participating in the hypersensitivity of infected mice.
    Kawakami M; Hara Y; Mitsuhashi S
    Jpn J Med Sci Biol; 1973 Feb; 26(1):18-22. PubMed ID: 4124713
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental salmonellosis: hypersensitivity to cell wall lipopolysaccharide and anti-infectious resistance of mice infected with Salmonella.
    Kawakami M; Hara Y; Osawa N
    Infect Immun; 1971 Nov; 4(5):519-24. PubMed ID: 4117290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental protective immunization of mice against S. typhimurium infection by Salmonella R mutants].
    Schlecht S
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):250-6. PubMed ID: 4154594
    [No Abstract]   [Full Text] [Related]  

  • 4. Defined salmonella antigens for detection of cellular and humoral immune responses in salmonella infected calves.
    Robertsson JA; Svenson SB; Renström LH; Lindberg AA
    Res Vet Sci; 1982 Sep; 33(2):221-7. PubMed ID: 6183722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies demonstrate multiple epitopes on the O antigens of Salmonella typhimurium LPS.
    Elkins K; Metcalf ES
    J Immunol; 1984 Oct; 133(4):2255-60. PubMed ID: 6206158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of polymyxin B on bacterial membranes. 1. Binding to the O-antigenic lipopolysaccharide of Salmonella typhimurium.
    Bader J; Teuber M
    Z Naturforsch C; 1973; 28(7):422-30. PubMed ID: 4358580
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of an artificial antigen simulating the Salmonella O-determinant 4 for determining antibodies to Salmonella group B O-antigen in immunoenzyme analysis].
    Tregub AV; Pokrovskiĭ VV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Feb; (2):19-23. PubMed ID: 2421504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms in antimicrobial immunity.
    Collins FM
    J Reticuloendothel Soc; 1971 Jul; 10(1):58-99. PubMed ID: 4941266
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunity against the Ehrlich ascites carcinoma produced by bacterial endotoxins.
    Hager EB; Bailey GL; Hampers CL; Merrill JP
    Transplant Proc; 1969 Mar; 1(1):124-5. PubMed ID: 4944208
    [No Abstract]   [Full Text] [Related]  

  • 11. [O-somatic and surface antigens in Salmonella].
    Ivanov KK
    Vestn Akad Med Nauk SSSR; 1973; 28(11):64-71. PubMed ID: 4594838
    [No Abstract]   [Full Text] [Related]  

  • 12. [Protection against experimental Salmonella typhimurium infection in mice. Immunostimulating activity of heterologous Salmonella S-forms, R-mutants, lipopolysaccharides and muramyl dipeptide in vaccines combined with S. typhimurium].
    Schlecht S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):414-25. PubMed ID: 6385567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer immunotherapy based on killing of Salmonella-infected tumor cells.
    Avogadri F; Martinoli C; Petrovska L; Chiodoni C; Transidico P; Bronte V; Longhi R; Colombo MP; Dougan G; Rescigno M
    Cancer Res; 2005 May; 65(9):3920-7. PubMed ID: 15867392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Salmonella-specific L3T4+ and Lyt-2+ T cells which can proliferate in vitro and mediate delayed-type hypersensitivity reactivity.
    Pope M; Kotlarski I
    Immunology; 1994 Feb; 81(2):183-91. PubMed ID: 7512525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
    Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
    J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation by haptenic Salmonella polysaccharides of murine and rabbit lymphocytes.
    Bona C; Damais C
    Ann Immunol (Paris); 1975; 126(2):191-9. PubMed ID: 1103719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The antigenic activity of a streptomycin dependent mutant of Salmonella enteritidis defective in lipopolysaccharide structure].
    Stanislavskiĭ ES; Edvabnaia LS
    Biull Eksp Biol Med; 1970 Feb; 69(2):73-5. PubMed ID: 5424244
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in delayed-type hypersensitivity responses in various mouse strains in the C3H lineage infected with Salmonella typhimurium, strain SL3235.
    Killar LM; Eisenstein TK
    J Immunol; 1984 Sep; 133(3):1190-6. PubMed ID: 6379046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the first (C1), the second (C2) and the fourth (C4) component of complement with different preparations of bacterial lipopolysaccharides and with lipid A.
    Loos M; Bitter-Suermann D; Dierich M
    J Immunol; 1974 Mar; 112(3):935-40. PubMed ID: 4590707
    [No Abstract]   [Full Text] [Related]  

  • 20. Some regularities of antibody formation in mice immunized by salmonella cell fractions.
    Stanislavsky ES; Fish NG; Balayan VD
    J Hyg Epidemiol Microbiol Immunol; 1971; 15(1):9-22. PubMed ID: 4928824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.